Silicon Valley Medical Technology President Convicted For Fraud – The National Law Review

On September 1, 2022, the president of Arrayit Corporation, a medical technology company in Silicon Valley, was convicted by a federal jury for his participation in a scheme involving the submission of over $77 million in false claims for COVID-19 and allergy testing.
According to court documents and trial evidence, the defendant engaged in a scheme to defraud the company’s investors by alleging that he had invented new technology that would be able to use only a few drops of blood to test for any disease. Trial evidence showed that the defendant misrepresented the company valuation to investors, claiming that the company could be valued at $4.5 billion based on supposed revenues of $80 million per year.
Trial evidence also showed that the defendant failed to release financial disclosures required by the SEC, and also hid from investors that Arrayit was near bankruptcy. The evidence further showed that the defendant induced investors by holding private meetings, and issuing press releases and tweets which falsely stated that the company had partnered with certain companies, public institutions, or government agencies, and fraudulently claimed that such entities had agreed to use the company technology.
The defendant also allegedly participated in a health care fraud scheme by paying kickbacks to marketers for patient blood specimens and then submitting fraudulent claims to Medicare and private insurance companies for unnecessary allergy testing. Arrayit allegedly ran allergy screening tests on every patient for 120 different allergens, regardless of medical necessity, and then the defendant falsely claimed that the company allergy testing kit was highly accurate in diagnosing allergies when it was not actually a diagnostic test. The evidence at trial showed that the company billed more per patient to Medicare for blood-based allergy testing than any other laboratory in the United States, and billed some commercial insurers over $10,000 per test.
Early in the COVID-19 pandemic, when there was a reduced demand for Arrayit’s allergy testing business, the defendant announced that the company “had a test for COVID-19” based on the company’s blood testing technology despite that the company had not yet developed such a test. The defendant then falsely advertised that Dr. Anthony Fauci and other government officials had mandated testing for COVID-19 and allergies simultaneously and required that patients receiving the company’s COVID-19 test also test for allergies. The defendant also falsely claimed that the company’s COVID-19 test was more accurate than a PCR test, when the Food and Drug Administration had notified him that the company’s test was not sufficiently accurate to receive an Emergency Use Authorization for use in the United States.
The defendant was convicted of one count of conspiracy to commit health care fraud and conspiracy to commit wire fraud, two counts of health care fraud, one count of conspiracy to pay kickbacks, two counts of payment of kickbacks, and three counts of securities fraud. He is scheduled to be sentenced in January 2023 and could face a penalty of up to 20 years in prison for the conspiracy to commit health care fraud and conspiracy to commit wire fraud charges; 10 years in prison for each count of health care fraud; five years in prison for conspiracy to pay kickbacks; 10 years in prison for each count of payment of kickbacks; and 20 years in prison for each count of securities fraud.
The DOJ press release can be found here.
On September 7, 2022, a former legislator in Puerto Rico was sentenced to 57 months in prison and was ordered to pay $190,000 in restitution for engaging in a bribery and kickback scheme. In March, the legislator pleaded guilty to federal program bribery in the District of Puerto Rico.
The legislator was elected to the Puerto Rico House of Representatives in 2016. He hired two individuals to work in his legislative office, and, according to court documents, each of the individuals paid biweekly kickbacks to the legislator ranging from $500 to $1,300 from 2017 to 2020 in exchange for their employment and salaries.
In the statements made with their pleas, the legislator and his employees admitted that the kickbacks were generally paid in cash in envelopes that the individuals provided to the legislator in the Capital building in Old San Juan. One of the individuals admitted that kickbacks were occasionally paid via a mobile phone cash transfer application.
The individuals that worked in the legislators’ office are scheduled to be sentenced later this month.
The DOJ press release can be found here.
About this Author
Jacques focuses his practice on government investigations and enforcement. Recognized as one of the top False Claims Act practitioners in the country, his clients largely encompass all branches of health care and life sciences. He has more than 30 years of experience handling jury, bench, and administrative trials in a variety of civil and criminal cases in state and federal courts throughout the country. Jacques excels at handling complex commercial disputes and internal investigations and responding to government inquiries. 
Jacques is…
Randy routinely litigates high-stakes matters in state and federal courts, including preliminary injunctions, motions practice, jury and bench trials, arbitrations, and mediation.
Randy often handles matters related to investigations and the False Claims Act, municipal bond finance, and trademark litigation. Randy also has represented agricultural chemical manufacturers in numerous data compensation disputes arising under the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA), environmental actions under CERCLA, employment, trade secret…
Rebecca has been involved in litigation in health care reimbursement disputes, commercial real estate, and complex torts, as well as government investigations involving health care fraud under the False Claims Act. She counsels health care providers on commercial payer disputes, particularly issues arising under ERISA and the Medicare Secondary Payer Act, and also has experience representing clients in the fashion and luxury goods industry.
Prior to joining ArentFox Schiff, Rebecca clerked for Chief…
Mattie has experience in a wide variety of complex litigation matters, including representing and advising regulated entities and trade associations in litigation related to regulatory registrations for biotechnical and agricultural products; and representing medical providers in disputes with commercial payers. Mattie represents clients in state and federal court, and in many phases of litigation, including discovery, motion practice, and appeals.
Prior to joining Arent Fox, Mattie drafted briefs,…
As a woman owned company, The National Law Review is a certified member of the Women's Business Enterprise National Council
You are responsible for reading, understanding and agreeing to the National Law Review’s (NLR’s) and the National Law Forum LLC’s  Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.  
Some states have laws and ethical rules regarding solicitation and advertisement practices by attorneys and/or other professionals. The National Law Review is not a law firm nor is  intended to be  a referral service for attorneys and/or other professionals. The NLR does not wish, nor does it intend, to solicit the business of anyone or to refer anyone to an attorney or other professional.  NLR does not answer legal questions nor will we refer you to an attorney or other professional if you request such information from us. 
Under certain state laws the following statements may be required on this website and we have included them in order to be in full compliance with these rules. The choice of a lawyer or other professional is an important decision and should not be based solely upon advertisements. Attorney Advertising Notice: Prior results do not guarantee a similar outcome. Statement in compliance with Texas Rules of Professional Conduct. Unless otherwise noted, attorneys are not certified by the Texas Board of Legal Specialization, nor can NLR attest to the accuracy of any notation of Legal Specialization or other Professional Credentials.
The National Law Review – National Law Forum LLC 3 Grant Square #141 Hinsdale, IL 60521  Telephone  (708) 357-3317 or toll free (877) 357-3317.  If you would ike to contact us via email please click here.


Leave a Comment